Abstract
The influences of zinc (Zn) and the nitric oxide synthase (NOS) inhibitor l-NAME on peripheral neuropeptide Y (NPY)-induced feeding in mice were investigated. Male mice received NPY (200 ng/d/mouse subcutaneously) and were separated into four groups based on cotreatments (with or without Zn [0.1 mg/mL]) and with or without l-NAME [0.2 mg/mL]) administered in drinking water for 10 d. A control group that received saline injection was also studied. The results showed that NPY, with or without any studied chemicals, did not affect body weight gain or body fat content. However, the mice that were administered NPY alone had increased energy intakes, higher serum triglyceride and free fatty acid, and lower serum glucose than saline-injected controls. NPY-treated mice that were given Zn and l-NAME cotreatments had compatible results of determined variables in comparison with control mice. This study showed that Zn and l-NAME attenuated NPY-mediated feeding and selected serum variables in mice. However, the mechanisms of the interactions among NPY, Zn and NOS, and their effects on appetite regulation, remain to be elucidated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
F. Squadrito, G. Calapai, D. Cucinotta, D. Altavilla, B. Zingarelli, M. Ioculano, et al., Anorectic activity of NG-nitro-l-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats, Eur. J. Pharmacol. 23, 125–128 (1993).
J. E. Morley and J. F. Flood, Effect of competitive antagonism of NO synthetase on weight and food intake in obese and diabetic mice, Am. J. Physiol. 266, R164-R168 (1994).
A. Stricker-Krongrad, B. Beck, and C. Burlet, Nitric oxide mediates hyperphagia of obese Zucker rats:relation to specific changes in the microstructure of feeding behavior, Life Sci. 58, PL9-PL15 (1996).
J. E. Morley, V. B. Kumar, M. Mattammal, and D. T. Villareal, Measurement of nitric oxide synthase and its mRNA in genetically obese (ob/ob) mice, Life Sci. 57, 1327–1331 (1995).
J. E. Morley and M. B. Mattammal, Nitric oxide synthase levels in obese Zucker rats, Neurosci. Lett. 209, 137–139 (1996).
J. E. Morley, Neuropeptide regulation of appetite and weight, Endocr. Rev. 8, 256–287 (1987).
A. Sahu and S. P. Kalra, Neuropeptidergic regulation of feeding behavior: neuropeptide Y, Trend Endocrinol. Metab. 4, 217–224 (1993).
M. L. Kennedy and M. L. Failla, Zinc metabolism in genetically obese (ob/ob) mice, J. Nutr. 117, 886–893 (1987).
C. McClain, M. Stuart, E. Kasarskis, and L. Humphries, Zinc, appetite regulation and eating disorders, in Essential and Toxic Trace Elements in Human Health and Disease: An Update, A. S. Prasad, ed., Wiley-Liss, New York, pp. 47–64 (1993).
J. H. Y. Park, C. J. Grandjean, M. H. Hart, S. H. Erdman, P. Pour, and J. A. Vanderhoof, Effect of pure zinc deficiency on glucose tolerance and insulin and glucagon levels, Am. J. Physiol. 251, E273-E278 (1986).
P. L. Selvais, C. Labuche, N. X. Ninh, J. Ketelslegers, J. Denef, and D. M. Maiter, Cyclic feeding behaviour and changes in hypothalamic galanin and neuropeptide Y gene expression induced by zinc deficiency in the rat, J. Neuroendocrinol. 9, 55–62 (1997).
R. G. Lee, T. M. Rains, C. Tovar-Palacio, J. L. Beverly, and N. F. Shay, Zinc deficiency increases hypothalamic neuropeptide Y and neuropeptide Y mRNA levels and does not block neuropeptide Y-induced feeding in rats, J. Nutr. 128, 1218–1223 (1998).
A. Persechini, K. McMillan, and B. S. S. Masters, Inhibition of nitric oxide synthase activity by Zn2+ ion, Biochemistry 34, 15,091–15,095 (1995).
D. Berendji, V. Kolb-Bachofen, K. L. Meyer, O. Grapenthin, H. Weber, V. Wahn, et al., Nitric oxide mediates intracytoplasmic and intranuclear zinc release, FEBS Lett. 405, 37–41 (1997).
S. P. Kalra, A. Sahu, P. S. Kalra, and W. R. Crowley, Hypothalamic neuropeptide Y: a circuit in the regulation of gonadotropin secretion and feeding behavior, Ann. NY Acad. Sci. 611, 273–283 (1990).
W. M. Bennet, Z. L. Wang, P. M. Jones, R. M. Wang, R. F. James, N. J. London, et al., Presence of neuropeptide Y and its messenger ribonucleic acid in human islets: evidence for a possible paracrine role, J. Clin. Endocrinol. Metab. 81, 2117–2120 (1996).
R. Vettor, C. Pagano, M. Granzotto, P. Englaro, P. Angeli, W. F. Blum, et al., Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats, Diabetologia 41, 1361–1367 (1998).
E. H. Leiter, F. Premdas, D. E. Harrison, and L. G. Lipson, Aging and glucose homeostasis in C57BL/6J male mice, FASEB J. 2, 2807–2811 (1988).
L. Cui, Y. Takagi, M. Wasa, K. Sando, J. Khan, and A. Okada, Nitric oxide synthase inhibitor attenuates intestinal damage induced bu zinc deficiency in rats, J. Nutr. 129, 792–798 (1999).
H. F. Mangian, R. G. Lee, G. L. Paul, J. L. Emmert, and N. F. Shay, Zinc deficiency suppresses plasma leptin concentrations in rats, J. Nutr. Biochem. 9, 47–51 (1998).
C. S. Mantzoros, A. S. Prasad, F. W. J. Beck, S. Grabowski, J. Kaplan, C. Adair, et al., Zinc may regulate serum leptin concentrations in humans, J. Am. Coll. Nutr. 17, 270–275 (1998).
G. Wolf, Neuropeptides responding to leptin, Nutr. Rev. 55, 85–88 (1997).
M. D. Chen, P. Y. Lin, and W. H. H. Sheu, Zinc status in plasma of obese individuals during glucose administration, Biol. Trace Element Res. 60, 123–129 (1997).
R. G. Knowles, and S. Moncada, Nitric oxide synthases in mammals, Biochem. J. 298, 249–258 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheng, CW., Lin, PY. & Chen, MD. Zinc and nitric oxide synthase inhibitor l-NAME attenuate NPY-induced feeding in mice. Biol Trace Elem Res 75, 21–27 (2000). https://doi.org/10.1385/BTER:75:1-3:21
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:75:1-3:21